NUWE · XBRL financial data
Nuwellis financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (NUWE's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | †Dec 31, 2023 | †Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 7,441 | 7,921 | 8,543 | 8,864 | 8,740 | 8,270 |
| Cost of goods and services sold | 3,384 | 3,430 | 3,788 | 3,881 | 3,064 | 3,146 |
| Gross profit | 4,057 | 4,491 | 4,755 | 4,983 | 5,676 | 5,124 |
| Research and development | 3,668 | 4,978 | 4,342 | 5,422 | 3,209 | 2,712 |
| Selling, general and administrative | 17,417 | 19,039 | 17,584 | 17,191 | 13,455 | 13,518 |
| Total operating expenses | 21,085 | 24,017 | 21,926 | 22,613 | 16,664 | 16,230 |
| Operating income (loss) | (17,028) | (19,526) | (17,171) | (17,630) | (10,988) | (11,106) |
| Other income (expense) | (1) | (43) | 75 | 154 | (80) | 10 |
| Income tax expense (benefit) | 9 | 9 | 9 | 8 | 5 | 5 |
| Net income (loss) | (15,836) | (19,578) | (14,525) | (20,209) | (11,165) | (17,521) |
| Earnings per share, basic‡ USD per share | (1,955,415,787.00) | (525,964,696.22) | (153,116,203.38) | (21,111,893.03) | (12,514.88) | (906.79) |
| Earnings per share, diluted‡ USD per share | (1,955,415,787.00) | (525,964,696.22) | (153,116,203.38) | (21,111,893.03) | (12,514.88) | (906.79) |
| Weighted average shares, basic‡ thousands of shares | 0 | 0 | 0 | 0 | 1 | 19 |
| Weighted average shares, diluted‡ thousands of shares | 0 | 0 | 0 | 0 | 1 | 19 |
- ‡ Per-share figures and share counts are adjusted for the 1-for-100 stock split (December 2022); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-35.714285714285715 stock split (June 2024); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-34.48275862068965 stock split (June 2024); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-41.666666666666664 stock split (July 2025); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-35.714285714285715 stock split (June 2026); filings made before it reported them unadjusted.
- † Share count changed about 4x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 735x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 22x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (NUWE's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | †Dec 31, 2023 | †Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 14,437 | 24,205 | 17,737 | 3,800 | 5,095 | 1,085 |
| Marketable securities | — | 15,463 | 569 | 0 | — | — |
| Accounts receivable | 905 | 750 | 1,406 | 1,951 | 1,727 | 1,493 |
| Inventory | 2,957 | 2,843 | 2,661 | 1,997 | 1,718 | 1,910 |
| Total current assets | 18,536 | 28,126 | 22,769 | 8,209 | 8,855 | 5,186 |
| Property and equipment, net | 1,200 | 1,188 | 980 | 728 | 478 | 368 |
| Right-of-use asset | 255 | 1,082 | 903 | 713 | 510 | 293 |
| Total assets | 20,012 | 30,417 | 24,673 | 9,770 | 9,864 | 6,118 |
| Accounts payable | 1,097 | 1,414 | — | — | — | — |
| Total current liabilities | 3,585 | 3,307 | 4,688 | 3,172 | 2,559 | 3,032 |
| Lease liability, non-current | 55 | 956 | 760 | 544 | 307 | 67 |
| Total liabilities | 3,694 | 4,470 | 12,316 | 6,559 | 3,334 | 3,488 |
| Accumulated deficit | (233,338) | (252,916) | (267,417) | (287,626) | (298,791) | (316,312) |
| Total stockholders' equity | 16,318 | 25,947 | 12,357 | 2,990 | 6,528 | 2,624 |
| Total liabilities and equity | 20,012 | 30,417 | 24,673 | 9,770 | 9,864 | 6,118 |
| Common shares outstanding (cover page)‡ thousands of shares | 0 | 0 | 0 | 0 | 3 | 65 |
- ‡ Per-share figures and share counts are adjusted for the 1-for-100 stock split (December 2022); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-35.714285714285715 stock split (June 2024); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-34.48275862068965 stock split (June 2024); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-41.666666666666664 stock split (July 2025); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-35.714285714285715 stock split (June 2026); filings made before it reported them unadjusted.
- † Share count changed about 4x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 735x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 22x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (NUWE's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | †Dec 31, 2023 | †Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (15,836) | (19,578) | (14,525) | (20,209) | (11,165) | (17,521) |
| Stock-based compensation | 1,349 | 1,314 | 862 | 670 | 478 | 127 |
| Depreciation and amortization | 376 | 488 | 372 | — | — | — |
| Net cash from operating activities | (16,572) | (17,880) | (15,149) | (17,937) | (9,591) | (10,810) |
| Purchases of property and equipment | 298 | 219 | 122 | 149 | 60 | 90 |
| Net cash from investing activities | (267) | (219) | 14,728 | 330 | (60) | (90) |
| Proceeds from issuing common stock | — | — | — | — | 2,403 | 3,999 |
| Net cash from financing activities | 30,016 | 27,871 | 9,423 | 3,683 | 10,962 | 6,940 |
| Net change in cash | 13,158 | 9,768 | 8,995 | (13,937) | 1,295 | (3,905) |
- † Share count changed about 4x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 735x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 22x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Nuwellis | 3,922 | 1,969 | (3,175)* | 3.6M | 1.2 quarters | 10-QJun 30, 2026 |
| Glucotrack | 1,124 | not reported | (3,616)* | 10.6M | 0.3 quarters | 10-QJun 30, 2026 |
| Catheter Precision | 643 | 1,019 | (2,861)* | 14.4M | 0.6 quarters | 10-QJun 30, 2026 |
| Aethlon Medical | 4,934 | not reported | (1,897) | 711,136 | 2.6 quarters | 10-QJun 30, 2026 |
| STRATA Skin Sciences | 7,912 | 9,292* | (239)* | 5.9M | 33.1 quarters | 10-KDec 31, 2025 |
| Encision | 72 | 1,528 | (127)* | 16.9M | 0.6 quarters | 10-QSep 30, 2025 |
| Family Office of America | 637 | 533 | 149* | 30.8M | — | 10-QJun 30, 2026 |
| Odyssey Health | 122 | not reported | (160)* | 110.2M | 0.8 quarters | 10-KJul 31, 2026 |
| Autonomix Medical | 3,460 | 0 | (3,544) | 971,043 | 1.0 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.